CLINICAL_TRIALS
ClinicalTrials.gov record update
Gold-silver-cuprous Oxide (Au-Ag-Cu2O) Composite Nanogel Combined With Photothermal Therapy in the Treatment of Severe Drug-resistant Microbial Keratitis
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05268718
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:46.285435+00:00
- Published At
- 2022-03-07T00:00:00+00:00
- Record Updated At
- 2022-03-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Keratitis, Ulcerative", "Antibiotic Resistance, Microbial", "Photothermal Therapy"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-07"- protocolSection.identificationModule.nctId
"NCT05268718"- protocolSection.identificationModule.officialTitle
"Gold-silver-cuprous Oxide (Au-Ag-Cu2O) Composite Nanogel Combined With Photothermal Therapy in the Treatment of Severe Drug-resistant Microbial Keratitis"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.